戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 spective of producing dietary supplements or pharmaceutical preparations.
2  fatty acids in food industry, cosmetics and pharmaceutical preparations.
3 d antispasmodic, also being included in some pharmaceutical preparations.
4 ntal surveillance and the quality control of pharmaceutical preparations.
5 iffusa species as an infusion or in food and pharmaceutical preparations.
6 e determination of FCV in pure solutions and pharmaceutical preparations.
7 lorie sweeteners and excipients for food and pharmaceutical preparations.
8 cine and traditional food, but also in novel pharmaceutical preparations.
9 urpose, to identify doping abuse, to analyze pharmaceutical preparation and even to detect cancer and
10  determination of vitamin B(1) (thiamine) in pharmaceutical preparation and food is described in this
11 the approaches to identifying labile iron in pharmaceutical preparations and body fluids and its pote
12 lications ranging from coatings and films to pharmaceutical preparations, and therefore DNA aptamers
13                            Enzynorm(R)f is a pharmaceutical preparation comprising fixed amounts of p
14 tional adjuvant, carrier protein, or special pharmaceutical preparation (e.g., liposomes).
15  species in food products, nutraceutical and pharmaceutical preparations for human health should also
16 e capable of discrimination between the same pharmaceutical preparations made by different manufactur
17 es to insulin hexamers is known to stabilize pharmaceutical preparations of the hormone.
18  insulin-dependent diabetic patients rely on pharmaceutical preparations of the Zn-insulin hexamer, w
19                                              Pharmaceutical preparations of these complex polysacchar
20 ve and quantitative analysis of AA or TAA in pharmaceutical preparations or fruit beverages.
21 al heparinase), as well as a heparin-derived pharmaceutical preparation Tinzaparin (heparin oligosacc
22 tion of maltose as an active ingredient in a pharmaceutical preparation was demonstrated.
23 s reduction to AA) in fruit beverages and in pharmaceutical preparations were compared.
24 ng miptodes for the determination of all the pharmaceutical preparations without the need for the dev